Panvel project applications target 31.17 lakh sq ft and ₹2,500 crore-plus value

Capex & Operations View source PDF Explain this filing

SUPREME · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+6.2%Reaction day

₹79.50

prior close

₹81.95

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%+6.4% vs market

Residential Commercial Projects peers, median of 60sector-0.1%+6.3% vs sector

On the reaction day the stock moved 6.4 pts more than Nifty Microcap 250 and 6.3 pts more than its Residential Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+4.7

10m

+4.9

15m

+4.4

30m

+4.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+6.2-0.2+6.4-0.1+6.3

Next day

+8.4+0.1+8.3+0.3+8.2

+6.9-0.6+7.5-0.3+7.3

+13.2-0.9+14.1-1.0+14.2

+10.0-1.3+11.3-2.0+12.0

+8.5-2.3+10.8-2.8+11.3

+9.6-5.2+14.7-5.3+14.9

15d

+21.9-2.9+24.8-3.8+25.6

+7.9-2.6+10.5-3.2+11.1

+5.7-2.9+8.6-4.9+10.6

-2.0-8.9+6.9-9.8+7.8

UpDownMarket · Nifty Microcap 250Sector · Residential Commercial Projects peers, median of 60Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The company applied for IOD approval and building permissions for its Panvel land parcels for a planned phased development with about 31.17 lakh square feet of potential saleable area. Estimated gross development value is expected to exceed ₹2,500 crore, subject to approvals, market conditions and regional infrastructure. No project timeline was disclosed.

Likely market impact

The projects could create significant future real estate value, but approval, market and infrastructure risks remain. No timeline was provided.